论文部分内容阅读
目的:探究血液分析仪检验急慢性白血病的临床应用效果。方法:选择我院2012年6月-2014年6月临床确诊为急慢性白血病的患者40例,其中慢性白血病患者8例,作为实验A组,急性白血病患者32例,作为实验B组;选择同期来我院体检的健康人40例,作为对照组。对三组患者的血样用血液分析仪进行检验,记录所有数据,并对数据进行对比分析。结果:血红蛋白:实验A组为(32.1±8.2)g/L,实验B组为(33.2±6.2)g/L,对照组为(118.7±18.9)g/L,实验A组和实验B组白血病患者的血红蛋白比重均低于对照组,差异具有统计学意义(P>0.05);CRP:实验A组为(186.4±3.9)mg/L,实验B组为(112.3±3.7)mg/L,对照组为(41.2±2.9)mg/L,白细胞数:实验A组为(107.1±0.4)×109/L,实验B组为(92.8±0.5)×109/L,对照组为(10.6±1.5)×109/L,实验A组和实验B组的CRP和白细胞数均高于对照组,差异具有统计学意义(P<0.05);同时实验A组与实验B组之间无明显差异(P>0.05),差异无统计学意义。结论:运用血液分析仪对白血病患者的血液进行检验临床效果好,能够检验出准确的结果,为临床诊断提供依据,具有一定的优势,值得临床推广应用。
Objective: To investigate the clinical application of hematology analyzer in the detection of acute and chronic leukemia. Methods: Forty patients with acute and chronic leukemia clinically diagnosed as acute and chronic leukemia from June 2012 to June 2014 in our hospital, including 8 chronic leukemia patients as experiment A group and 32 acute leukemia patients as experimental group B, 40 healthy people who came to our hospital for physical examination served as control group. Blood samples from three groups of patients were tested with a blood analyzer, all data were recorded, and the data were analyzed comparatively. Results: Hemoglobin in experimental group A was (32.1 ± 8.2) g / L, in experimental group B was (33.2 ± 6.2) g / L, in control group was (118.7 ± 18.9) g / L, in experimental group A and group B leukemia (P> 0.05). The CRP was (186.4 ± 3.9) mg / L in the experimental group A and (112.3 ± 3.7) mg / L in the experimental group B, and the control group was significantly lower than the control group (41.2 ± 2.9) mg / L and white blood cell count (107.1 ± 0.4) × 109 / L in experimental group A and (92.8 ± 0.5) × 109 / L in experimental group B and × 109 / L, CRP and leukocyte count in experimental group A and group B were significantly higher than those in control group (P <0.05), while there was no significant difference between experimental group A and group B (P> 0.05), the difference was not statistically significant. Conclusion: The blood analyzer for leukemia patients with good clinical test results, able to test out accurate results, provide the basis for clinical diagnosis, has some advantages, it is worth promoting the clinical application.